Martine Etienne-Mesubi

Dr. Martine Etienne-Mesubi


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
AAAnthony Amoroso
Anthony Amoroso
MEMartine Etienne-Mesubi
Martine Etienne-Mesubi
AEAnthony Edozien
Anthony Edozien
SOSylvia Ojoo
Sylvia Ojoo
RSRobert Sheneberger
Robert Sheneberger
RRRobert R. Redfield
Robert R. Redfield
Although used globally, little data exist on the efficacy of nevirapine (NVP) used in combination with tenofovir (TDF)/emtricitabine or lamivudine (XTC), and no large randomized prospective control trials exists comparing this combination with efavirenz (EFV)/TDF/(XTC). As part of the AIDSRelief program, a retrospective review of patient medical chart information along with a cross-sectional viral load, and adherence measurement was conducted between 2004 and 2009. An on-treatment analysis excluded patients who died, transferred out of care, or were lost to follow-up. A switch of antiretrovirals for any reason was considered a failure in the intent-to-treat analysis. Patients with only clinically relevant reasons for switching such as toxicity, adverse effects, viral failure or clinical/immunological failure, lost to follow-up, and death were considered failures as part of the modified-intent-to-treat analysis. Step-wise multiple regression analysis was used to identify variables that were associated with viral suppression. A random sample of 3862 patients met criteria and were included in this analysis. In the on-treatment analysis, older age (P < 0.004) and baseline CD4 <100 cells per cubic millimeter (P < 0.021) were the most significant variables impacting viral load. Patients on TDF/XTC/EFV achieved higher rates of viral suppression compared with patients on TDF/XTC/NVP or azidothymidine (AZT)/lamivudine (3TC)/NVP. Our data show that patients on TDF/XTC/EFV had better outcomes than patients on TDF/XTC/NVP, AZT/3TC/EFV, or AZT/3TC/NVP. High rates of virologic suppression seen in patients on this regimen are consistent with previous studies and indicate the need to increase use of this regimen in HIV programs to promote sustainable viral suppression over time.

14 October 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
MEMartine Etienne-Mesubi
Martine Etienne-Mesubi
BOBabatunji Oni
Babatunji Oni
NLNancy Rachel Labbe-Coq
Nancy Rachel Labbe-Coq
MAMarie Colette Alcide-Jean-Pierre
Marie Colette Alcide-Jean-Pierre
DLDelva Lamarre
Delva Lamarre
DBDeus Bazira
Deus Bazira
Introduction: The COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. In 2022, the population of Haiti was 11.4 million. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats. Methods: This was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Participants consisted of adults in this setting responding to a survey from June 15 to July 18, 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussion participants were recruited and focus group discussions were conducted between August-September 2022 among community groups, religious leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines. Results: A total of 1,923 respondents completed the survey; of which a majority were male (52.7%), between the age of 18–35 (58.5%), had a medical visit within the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p < .0001), have completed secondary education (30.5% vs 16.6%, p < .001), unemployed (20.3% vs 7.3%, p < .0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p < .0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p < .0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p < .0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p < .0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, p<0.0001). Conclusion: These results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.

11 January 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MEMartine Etienne-Mesubi
Martine Etienne-Mesubi
BOBabatunji Oni
Babatunji Oni
NLNancy Rachel Labbe-Coq
Nancy Rachel Labbe-Coq
MAMarie Colette Alcide-Jean-Pierre
Marie Colette Alcide-Jean-Pierre
DLDelva Lamarre
Delva Lamarre
DBDeus Bazira
Deus Bazira
Introduction The COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats. Methods This was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Survey participants consisted of adults of this setting responding to an electronic survey between June – Sept 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussions were conducted among community leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines. Results A total of 1,923 respondents completed the survey; of which a majority were male (52.7%), were between the age of 18-35 (58.5%), had a medical visit with the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p<.0001), have classical education (30.5% vs 16.6%, p<.001), unemployed (20.3% vs 7.3%, p<.0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p<.0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p<.0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p<.0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p<.0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, p<0.0001). Conclusion These results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.